Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 4/20 | 0.62 |
| ▸ | HTT | P42858 | 3/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 7/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 3/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.48 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.48 |
| ▸ | RELA | Q04206 | 2/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9768625 | 0.89 | MAPT (0.79) | TDP1LMNAHTTL3MBTL1MAPT | |
| SCHEMBL11073261 | 0.84 | TDP1 (0.63) | TDP1LMNAHTTL3MBTL1MAPT | |
| SCHEMBL11065466 | 0.81 | TDP1 (0.60) | TDP1LMNAHTTL3MBTL1MAPT | |
| SCHEMBL1820467 | 0.80 | TDP1 (1.00) | TDP1LMNAHTTL3MBTL1MAPT | |
| SCHEMBL4549451 | 0.79 | MAPT (0.58) | TDP1LMNAHTTL3MBTL1MAPT | |
| SCHEMBL1822332 | 0.77 | TDP1 (0.74) | TDP1LMNAHTTL3MBTL1MAPT | |
| SCHEMBL3242008 | 0.77 | LMNA (1.00) | TDP1LMNAHTTL3MBTL1MAPT | |
| SCHEMBL24359770 | 0.76 | PDE10A (0.42) | TDP1LMNAHTTL3MBTL1MAPT | |
| SCHEMBL6884461 | 0.76 | PTGS2 (0.66) | TDP1MAPTKMT2AMEN1POLB | |
| SCHEMBL1187206 | 0.73 | PKM (0.64) | TDP1LMNAHTTL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6941051-B2 | Method for producing non-linear optical organic crystal film | REVEO, INC. (US) | 2005-09-06 | — | — | US | claimed |
| US-20040033038-A1 | Method for producing non-linear optical organic crystal film | XU JIANJUN (US) | 2004-02-19 | — | — | US | claimed |
| CN-1459047-A | Method for producing non-linear optical organic crystal film | REVEO INC (US) | 2003-11-26 | — | — | CN | claimed |
| US-6577798-B2 | Method for producing non-linear optical organic crystal film | REVEO, INC. | 2003-06-10 | — | — | US | claimed |
| US-20020041427-A1 | Method for producing non-linear optical organic crystal film | REVEO, INC. | 2002-04-11 | — | — | US | claimed |
| WO-2002008828-A2 | COMPOSITE NONLINEAR OPTICAL FILM, METHOD OF PRODUCING THE SAME AND APPLICATIONS OF THE SAME | REVEO, INC. (US) | 2002-01-31 | — | — | WO | claimed |
| WO-2002006890-A2 | METHOD FOR PRODUCING NON-LINEAR OPTICAL ORGANIC CRYSTAL FILM | REVEO, INC. (US) | 2002-01-24 | — | — | WO | claimed |
| US-6303056-B1 | Composite nonlinear optical film, method of producing the same and applications of the same | REVEO, INC. | 2001-10-16 | — | — | US | claimed |
| EP-0418916-B1 | Optical wavelength converting method | FUJI PHOTO FILM CO LTD (JP) | 1995-08-09 | — | — | EP | claimed |
| US-5080507-A | OPTICAL WAVELENGTH CONVERTING METHOD | FUJI PHOTO FILM CO., LTD. (JP) | 1992-01-14 | — | — | US | claimed |
| EP-0418916-A2 | Optical wavelength converting method | Fuji Photo Film Co., Ltd. (JP) | 1991-03-27 | — | — | EP | claimed |
| JP-4157429-A | — | — | None | — | — | JP | disclosed |
| JP-4157430-A | — | — | None | — | — | JP | disclosed |
| EP-3564232-B1 | BMP-SIGNAL-INHIBITING COMPOUND | RIKEN (JP) | 2022-01-26 | — | — | EP | disclosed |
| US-10954216-B2 | BMP-signal-inhibiting compound | RIKEN (JP) | 2021-03-23 | — | — | US | disclosed |
| US-4952013-A | Optical wavelength converter device | FUJI PHOTO FILM CO., LTD. (JP) | 1990-08-28 | — | — | US | disclosed |
| US-4909596-A | Optical wavelength converter module | FUJI PHOTO FILM CO., LTD. (JP) | 1990-03-20 | — | — | US | disclosed |
| US-4909596-A | Optical wavelength converter module | FUJI PHOTO FILM CO., LTD. (JP) | 1990-03-20 | — | — | US | disclosed |
| EP-0334363-A2 | Optical wavelength converter device | Fuji Photo Film Co., Ltd. (JP) | 1989-09-27 | — | — | EP | disclosed |
| US-4830447-A | Optical wavelength conversion device | FUJI PHOTO FILM CO., LTD. (JP) | 1989-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10954216-B2 | BMP-signal-inhibiting compound | BMP1, BMP2, BMP4 | TDP1 4110/4885LMNA 1065/4885HTT 4828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.